Trulieve Cannabis (TCNNF) Cost of Revenue (2020 - 2026)

Trulieve Cannabis' Cost of Revenue history runs 7 years deep, the most recent figure standing at $116.7 million for Q1 2026.

• In Q1 2026, Cost of Revenue rose 1.86% year-over-year to $116.7 million; the TTM figure through Mar 2026 stood at $472.1 million (up 2.31% YoY), while the FY2025 annual figure was $470.0 million, changed 0.16% from the prior year.
• Cost of Revenue was $116.7 million for Q1 2026 at Trulieve Cannabis, down from $118.0 million in the prior quarter.
• In the past five years, Cost of Revenue ranged from a high of $359.4 million in Q4 2023 to a low of $59.4 million in Q3 2023.
• Historically, Cost of Revenue has averaged $136.7 million across 5 years, with a median of $118.3 million in 2025.
• The sharpest annual moves came in 2022 and 2024: Cost of Revenue soared 2363.55% in 2022, then plunged 68.24% in 2024.
• A 5-year view of Cost of Revenue shows it stood at $309.4 million in 2022, then gained by 16.14% to $359.4 million in 2023, then slumped by 68.24% to $114.1 million in 2024, then increased by 3.38% to $118.0 million in 2025, then retreated by 1.11% to $116.7 million in 2026.
• The last three Cost of Revenue figures came in at $116.7 million (Q1 2026), $118.0 million (Q4 2025), and $118.3 million (Q3 2025), per Business Quant data.